back to top

Pakistan facing yellow fever vaccine shortage, travelers in limbo

Islamabad: Yellow fever vaccine has become unavailable across Pakistan, leaving people travelling to several African and South American countries struggling to meet mandatory vaccination requirements, as regulatory issues involving a Russian-manufactured vaccine have delayed fresh supplies, health and drug regulatory officials said.


Officials at Border Health Services (BHS) vaccination centres in Islamabad, Lahore, Peshawar and other international departure stations said travellers were repeatedly approaching them for yellow fever vaccination and internationally recognised certificates, but the vaccine was currently unavailable at government facilities, private hospitals and pharmacies.


They said the shortage was affecting people travelling to countries where proof of yellow fever vaccination is mandatory for entry under national regulations consistent with the International Health Regulations (IHR), administered by the World Health Organisation (WHO).


According to health officials, some intending travellers had also approached the National Institute of Health (NIH) in Islamabad to obtain the vaccine, but the institute was unable to provide it because of the shortage.


Officials said Border Health Services, which is responsible for administering yellow fever vaccines and issuing vaccination certificates to international travellers, had procured a Russian-manufactured vaccine to meet the country’s requirements. However, its import had been delayed because of registration-related formalities with the Drug Regulatory Authority of Pakistan (DRAP).


DRAP officials said the authority’s Registration Board had already approved the Russian-manufactured yellow fever vaccine, but certain documents were still awaited before formal authorisation for its import could be issued.


They said the remaining regulatory process would be completed after submission and examination of the required documentation, allowing the authorities to proceed with importing the vaccine.


However, health officials said even after the completion of the registration process and issuance of formal import permission, it would take at least another month for the vaccine to reach Pakistan and become available at designated vaccination centres.


According to DRAP officials, only one yellow fever vaccine, associated with Sanofi Aventis and now listed under Hoechst, is currently registered with the authority. However, the registered vaccine is also unavailable in Pakistan, leaving travellers without an accessible alternative.


The issue was also brought to the notice of Federal Health Minister Syed Mustafa Kamal, and his comments were sought regarding the shortage, regulatory delays and measures being taken to restore supplies. However, the minister did not respond to the queries.


Health officials said travellers intending to visit several African countries were particularly affected because they were required to present a valid International Certificate of Vaccination or Prophylaxis (ICVP), commonly known as the yellow card, before entering their destinations.


Under the International Health Regulations (2005), countries may require travellers to provide proof of yellow fever vaccination to prevent the international spread of the disease. The vaccination certificate becomes valid 10 days after administration of the vaccine and remains valid for the lifetime of the vaccinated person.


According to the WHO, yellow fever is an acute viral haemorrhagic disease transmitted to humans through the bites of infected mosquitoes. The disease occurs mainly in tropical regions of Africa and Central and South America, where infected mosquitoes can transmit the virus between humans and non-human primates.


The initial symptoms include fever, headache, muscle pain, nausea, vomiting and weakness. While many patients recover, some develop severe illness involving jaundice, bleeding and liver or kidney failure.


WHO says approximately half of patients who develop the severe phase of yellow fever die within seven to 10 days. There is no specific antiviral treatment for the disease, and medical care focuses on managing symptoms and complications.


The organisation identifies vaccination as the most effective means of preventing yellow fever and recommends immunisation for eligible people travelling to areas where the disease is endemic or where transmission is occurring.


According to WHO, a single dose of yellow fever vaccine provides lifelong protection for most people, and routine booster doses are generally not required. However, the vaccine should ordinarily be administered at least 10 days before international travel to allow the vaccination certificate to become valid.


Yellow fever vaccination requirements vary between countries. Some countries require proof of vaccination from all arriving travellers, while others impose the requirement only on people arriving from countries with a risk of yellow fever transmission or those who have transited through such countries.


Countries requiring yellow fever vaccination certificates from all arriving travellers include Angola, Benin, Burkina Faso, Burundi, Cameroon, the Central African Republic, the Republic of Congo, the Democratic Republic of Congo, Côte d’Ivoire, Gabon, Ghana, Guinea, Guinea-Bissau, Mali, Niger, Sierra Leone, South Sudan, Togo and Uganda.


Bolivia and French Guiana also have yellow fever vaccination requirements, although their application may depend on the traveller’s itinerary and the specific entry regulations in force.


Several other countries in Africa, Asia, the Middle East and Latin America require proof of yellow fever vaccination from travellers arriving from countries where the disease occurs, even when yellow fever is not endemic in the destination country.


International travel health guidelines state that travellers who fail to produce a required vaccination certificate may face refusal of entry, quarantine or other measures prescribed by the destination country.


Health officials said the shortage had created difficulties for people who had already obtained visas, purchased airline tickets or completed arrangements for employment, business and other visits abroad.


They pointed out that even after fresh vaccine supplies became available, people receiving yellow fever vaccination for the first time would have to wait at least 10 days before their certificates became internationally valid.


Officials said BHS vaccination centres were continuing to receive inquiries from travellers, but they could not provide vaccination services until fresh supplies became available.


They maintained that the immediate requirement was completion of the pending documentation and import formalities for the Russian-manufactured vaccine, followed by its distribution to designated vaccination centres.


Health officials said there was no confirmed date for the restoration of yellow fever vaccination services, while the import process itself was expected to take at least one month after regulatory clearance.

Get in Touch

spot_imgspot_img

Related Articles

Get in Touch

1,500FansLike
2,000FollowersFollow
230FollowersFollow
500SubscribersSubscribe

Latest Posts